In agreement, Vrillon and colleagues reported the existence of a close association between increased plasma levels of NRG1, cognitive decline, and synaptic dysfunction, suggesting its role as a potential non-invasive biomarker for monitoring neuronal damage in AD [107]. Here, NRG1 is linked to Alzheimer disease.